Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
three
months ended in Mar. 2026,
Dentsply Sirona paid$0 Mil more to buy back shares than it received from issuing new shares.
It spent$82 Mil paying down its debt.
It paid$0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It spent$32 Mil paying cash dividends to shareholders.
It spent$5 Mil on other financial activities.
In all, Dentsply Sironaspent$119 Mil on financial activities for the
three
months ended in Mar. 2026.
Dentsply Sirona (NAS:XRAY) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Dentsply Sirona's issuance of stock for the
three
months ended in Mar. 2026 was $0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Dentsply Sirona's repurchase of stock for the
three
months ended in Mar. 2026 was $0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Dentsply Sirona's net issuance of debt for the
three
months ended in Mar. 2026 was $-82 Mil.
Dentsply Sirona spent$82 Mil paying down its debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Dentsply Sirona's net issuance of preferred for the
three
months ended in Mar. 2026 was $0 Mil.
Dentsply Sirona paid$0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Dentsply Sirona's cash flow for dividends for the
three
months ended in Mar. 2026 was $-32 Mil.
Dentsply Sirona spent$32 Mil paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Dentsply Sirona's other financing for the
three
months ended in Mar. 2026 was $-5 Mil.
Dentsply Sirona spent$5 Mil on other financial activities.
Dentsply Sirona Cash Flow from Financing Related Terms
Dentsply Sirona Cash Flow from Financing Historical Data
* Premium members only.
The historical data trend for Dentsply Sirona's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dentsply Sirona Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Dentsply Sirona's Cash from Financing for the fiscal year that ended in Dec. 2025 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-322 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of $-322 Mil mean?
Dentsply Sirona (XRAY) has a Cash Flow from Financing of $-322 Mil as of Mar. 2026. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Dentsply Sirona and its competitors.
Is Dentsply Sirona's Cash Flow from Financing too high?
Dentsply Sirona's current Cash Flow from Financing is $-322 Mil. Overall, Dentsply Sirona has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dentsply Sirona's Cash Flow from Financing compare to LMAT and PLSE?
Dentsply Sirona's Cash Flow from Financing of $-322 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Medical Devices & Instruments company?
A good Cash Flow from Financing depends on the Medical Devices & Instruments industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Dentsply Sirona and its competitors. Dentsply Sirona's current Cash Flow from Financing is $-322 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dentsply Sirona stock overvalued right now?
Based on GuruFocus' analysis, Dentsply Sirona (XRAY) is currently considered Modestly Undervalued. The stock's GF Value™ is $19.01, compared to a current price of $14.05 — trading 26.1% below its estimated fair value. The current Cash Flow from Financing is $-322 Mil. Dentsply Sirona's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Dentsply Sirona (XRAY), the current Cash Flow from Financing is $-322 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dentsply Sirona (XRAY) Overvalued in 2026?
Based on GuruFocus' analysis, Dentsply Sirona stock appears to be undervalued.
The current stock price of $14.05 is trading 26.1% below its estimated GF Value™ of $19.01.
GuruFocus considers Dentsply Sirona to be Modestly Undervalued.
Key valuation signals for XRAY:
Cash Flow from Financing: $-322 Mil
GF Value™: $19.01 vs. price of $14.05 (26.1% below fair value)
No single metric tells the full story. See the XRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
55GF Score
Get the complete analysis for XRAY
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XRAY has been successfully added to your 
